SCHEMBL30837876

SCHEMBL30837876

COc1ccc(Cn2c(=O)c3cc(OCC(F)F)ccc3n(C3CCN(C=O)CC3C)c2=O)cc1OC

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.80
PDE7B Q9NP56 5/20 0.62
PDE8A O60658 3/20 0.62
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.36
KMT2A Q03164 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TP53 P04637 2/20 0.36
HCRTR1 O43613 2/20 0.36
HCRTR2 O43614 2/20 0.36
MAPK1 P28482 2/20 0.35
GAA P10253 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
DRD2 P14416 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL99982 1.00 PDE7A (0.80) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100674 0.90 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100608 0.89 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837886 0.89 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100810 0.88 PDE7A (0.84) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100080 0.87 PDE7A (0.95) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100956 0.84 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100673 0.84 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837950 0.84 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL99972 0.83 PDE7A (0.89) PDE7APDE7BPDE8APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed